Literature DB >> 34161127

CT and MRI Findings of Invasive Mucormycosis in the Setting of COVID-19: Experience From a Single Center in India.

Anagha Rajeev Joshi1, Mridula Manohar Muthe1, Soniya Hemant Patankar1, Ashish Athawale1, Yash Achhapalia2.   

Abstract

An increasing incidence of rhinoorbitocerebral mucormycosis (ROCM) among patients with COVID-19 has recently been reported in India. We report the imaging findings for 25 patients with COVID-19 and invasive ROCM at a single hospital in India. Findings included sinus wall erosions (n = 20), air within bony sinus structures (n = 11), and focal mucosal nonenhancement (n = 8). Orbital, vascular, and intracranial complications were also observed. Radiologists should recognize the increasing incidence of ROCM among patients with COVID-19 to facilitate early diagnosis.

Entities:  

Mesh:

Year:  2021        PMID: 34161127     DOI: 10.2214/AJR.21.26205

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  12 in total

Review 1.  Mucormycosis and COVID-19-Associated Mucormycosis: Insights of a Deadly but Neglected Mycosis.

Authors:  Laura C García-Carnero; Héctor M Mora-Montes
Journal:  J Fungi (Basel)       Date:  2022-04-25

Review 2.  COVID-19 associated mucormycosis - An emerging threat.

Authors:  Chien-Ming Chao; Chih-Cheng Lai; Wen-Liang Yu
Journal:  J Microbiol Immunol Infect       Date:  2022-01-13       Impact factor: 10.273

3.  COVID-19-associated rhino-orbital-cerebral mucormycosis: A systematic review, meta-analysis, and meta-regression analysis.

Authors:  Anusuya Bhattacharyya; Phulen Sarma; Hardeep Kaur; Subodh Kumar; Jaimini Bhattacharyya; Manisha Prajapat; Ajay Prakash; Saurabh Sharma; Dibbanti Harikrishna Reddy; Prasad Thota; Seema Bansal; Bhaswati Sharma Gautam; Bikash Medhi
Journal:  Indian J Pharmacol       Date:  2021 Nov-Dec       Impact factor: 1.200

4.  The Integral Role of Radiology in the Diagnosis and Management of COVID-19-Associated Mucormycosis Infections.

Authors:  Anuj Prabhakar; Nidhi Prabhakar; Mandeep Garg; Ajay Kumar
Journal:  Am J Trop Med Hyg       Date:  2022-02-09       Impact factor: 2.345

Review 5.  Clinical Features and Mortality of COVID-19-Associated Mucormycosis: A Systematic Review and Meta-Analysis.

Authors:  Atsuyuki Watanabe; Matsuo So; Hayato Mitaka; Yoshiko Ishisaka; Hisato Takagi; Ryota Inokuchi; Masao Iwagami; Toshiki Kuno
Journal:  Mycopathologia       Date:  2022-03-21       Impact factor: 3.785

6.  Mucormycosis and COVID-19: manifestations of the central nervous system and the ocular system.

Authors:  Michelle Ariana Polo Martínez; Rita Fernanda Campo Jiménez; Jorge Andrés Castrillón Lozano
Journal:  Ther Adv Infect Dis       Date:  2022-03-11

Review 7.  Mucormycosis and COVID-19 pandemic: Clinical and diagnostic approach.

Authors:  Asim Azhar; Wajihul Hasan Khan; Parvez Anwar Khan; Khaled Alhosaini; Mohammad Owais; Aijaz Ahmad
Journal:  J Infect Public Health       Date:  2022-02-18       Impact factor: 3.718

Review 8.  COVID-19-associated mucormycosis of head-and-neck region: A systematic review.

Authors:  Mamata Kamat; Uma Datar; Sanjay Byakodi; Sharad Kamat; Varsha Vimal Kumar
Journal:  J Clin Transl Res       Date:  2022-01-03

Review 9.  Mortality-Related Risk Factors for Coronavirus Disease (COVID-19)-Associated Mucormycosis: a systematic review and meta-analysis.

Authors:  Vahid Reza Ostovan; Reza Tabrizi; Hanieh Bazrafshan; Zahra Bahrami; Hajar Khazraei; Samaneh Khazraei; Afshin Borhani-Haghighi; Mohsen Moghadami; Matthew Grant
Journal:  Curr Fungal Infect Rep       Date:  2022-08-11

Review 10.  COVID-19 and mucormycosis superinfection: the perfect storm.

Authors:  Jaffar A Al-Tawfiq; Saad Alhumaid; Abeer N Alshukairi; Mohamad-Hani Temsah; Mazin Barry; Abbas Al Mutair; Ali A Rabaan; Awadh Al-Omari; Raghavendra Tirupathi; Manaf AlQahtani; Salma AlBahrani; Kuldeep Dhama
Journal:  Infection       Date:  2021-07-24       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.